Form 4 for YARW Yarrow Bioscience, Inc.
Accepted 2022-10-04 00:00:00 ET · period of report 2022-09-30 · accession 0001209191-22-052350 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-04 | 2022-09-30 | YARW | Domzalski David | Pres, CEO, Dir | F - Tax | $0.22 | -10.7K | 1.04M | -1% | -$2,350 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-30 | F | D | 10,683 | $0.22 | 1,040,270 | D | — | — | (F1) Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |